Indian spy's role alleged in Sri Lankan president's election defeat

January 18, 2015

Lankan president

Colombo/New Delhi, Jan 18: Sri Lanka expelled the Colombo station chief of India's spy agency in the run-up to this month's presidential election, political and intelligence sources said, accusing him of helping the opposition oust President Mahinda Rajapaksa.

An Indian foreign ministry spokesman denied any expulsion and said that transfers were routine decisions. Rajapaksa, voted out of office in the Jan 8 election, told Reuters he did not know all the facts while the new government in Colombo has said it is aware of the reports but cannot confirm them.

But several sources in both Colombo and New Delhi said India was asked to recall the agent in December for helping gather support for joint opposition candidate Maithripala Sirisena after persuading him to ditch Rajapaksa's cabinet.

A sketchy report in Sri Lanka's Sunday Times newspaper on December 28 said that "links with the common opposition" had cost India's Research and Analysis Wing (RAW) station chief his job in Colombo.

India has often been involved in the internal politics of the small island nation off its southern coast - it sent troops there in 1987 in a botched effort to broker peace between the government and Tamil Tiger rebels.

Rajapaksa's unexpected defeat after two terms in office coincided with growing concern in India that it was losing influence in Sri Lanka because of the former president's tilt toward regional rival China.

The concern turned to alarm late last year when Rajapaksa allowed two Chinese submarines to dock in Sri Lanka without warning New Delhi as he should have under a standing agreement, the sources said.

Sirisena, the new president, has said he will visit New Delhi on his first foreign trip next month and has said India is the "first, main concern" of his foreign policy.

An Indian official said the RAW agent was recalled after complaints that he had worked with Sri Lanka's usually fractious opposition parties to agree on a joint contender for the election. Then, he was accused of facilitating meetings to encourage several lawmakers, among them Sirisena, to defect from Rajapaksa's party, the official said.

The agent was accused of playing a role in convincing the main leader of the opposition and former prime minister Ranil Wickremasinghe not to contest against Rajapaksa in the election and stand aside for someone who could be sure of winning, said the officer and a Sri Lankan lawmaker who also maintains close contacts with India.

The agent was also in touch with former president Chandrika Kumaratunga, who was a key player in convincing Sirisena to stand, said the officer and the lawmaker, who also confirmed that the agent had been asked to leave.

"They actively were involved, talking to Ranil, getting those things organised, talking to Chandrika," the lawmaker told Reuters.

"Certain Things You Don't Talk About"

Wickremasinghe, who is now prime minister again in Sirisena's government, met "two or three times" with the man identified as the agent in the months before the vote, as well as with the Indian high commissioner, or ambassador, the prime minister's spokesman said.

"They discussed the current political situation," Wickremasinghe's spokesman said, but he denied that the Indians had advised him. "He does not know if he advised other politicians."It was not clear if Wickremasinghe was aware at the time that he was meeting with an intelligence official. India's RAW officers are usually given diplomatic posts when assigned to foreign missions.

Former president Kumaratunga did not respond to requests for comment.

Rajapaksa declined to confirm the involvement of India in the campaign against him.

"I don't know, I won't suspect anybody until I get my real facts," he said at his party headquarters.

"There are certain things you don't talk about," a close associate of the Rajapaksa family said, but added that "there were clear signs of a deep campaign by foreign elements."

Sri Lanka's then defence secretary Gotabaya Rajapaksa - a brother of the former president - complained about the agent's activities to Indian National Security Adviser Ajit Doval in November when Doval was visiting the island nation for a defence seminar, the Indian official said.

Another Indian official, who monitors the region for security threats, said New Delhi had been watching Beijing's growing influence and heavy investments in Sri Lanka under Rajapaksa, who visited China seven times since becoming president in 2005.

But India was stunned and angry last year when the Chinese submarines docked in Sri Lanka on two separate occasions, a step New Delhi saw as part of Beijing's "string of pearls" strategy to secure a foothold in South Asia and maritime access through the Indian Ocean.

"The turning point in the relationship was the submarines. There was real anger," the Indian security official said.

Indian military officials said that New Delhi reminded Sri Lanka it was obliged to inform its neighbours about such port calls under a maritime pact, and Indian Prime Minister Narendra Modi raised the issue with Rajapaksa at a meeting in New York.

In a possible sign of shifting allegiances, India's top envoy in Colombo, High Commissioner Y.K. Sinha, presented Sirisena with a large bouquet of flowers just hours after the results were announced on Jan 9. China's ambassador was only able to meet the new president six days later.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 6,2020

Italian researchers have claimed that they have successfully developed a vaccine to contain coronavirus (COVID-19) which is likely to work on humans, a report said.

Luigi Aurisicchio, CEO of Takis, the firm developing the medication, said that a coronavirus candidate vaccine has neutralised the virus in human cells for the first time, the Arab News reported.

"This is the most advanced stage of testing of a candidate vaccine created in Italy. Human tests are expected after this summer," Aurisicchio was quoted as saying to Italian news agency ANSA.

"According to the Spallanzani Hospital, as far as we know we are the first in the world so far to have demonstrated neutralisation of the coronavirus by a vaccine. We expect this to happen in humans too," he added.

The researchers experimented with the vaccine on mice that had successfully developed antibodies that blocked the virus from infecting the cells. They further observed that the five vaccine candidates generated a large number of antibodies, and selected two with the best results.

All of the vaccine candidates currently being developed are based on the genetic material of DNA protein "spike", the molecular tip used by the coronavirus to enter human cells.

They are injected with the so-called "electroporation" technique, which consists of an intramuscular injection followed by a brief electrical impulse, helping the vaccine break into the cells and activating the immune system, the report said.

Researchers believe that this makes their vaccine particularly effective for generating functional antibodies against the "spike" protein, in particular in the lung cells, which are the most vulnerable to coronavirus.

"We are working hard for a vaccine coming from Italian research, with an all-Italian and innovative technology, tested in Italy and made available to everyone," Aurisicchio was quoted by the Arab News report.

"In order to reach this goal, we need the support of national and international institutions and partners who may help us speed up the process," he noted.

The total number of COVID-19 infections, fatalities and recoveries since the pandemic began has risen to 213,013 in the country.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 25,2020

Beijing:  Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 30,2020

Geneva, Mar 30: The number of confirmed COVID-19 cases worldwide has reached 634,835, among them 29,957 fatalities, the World Health Organization (WHO) said on Sunday.

Over the past 24 hours, 63,159 people were confirmed to be infected with the novel coronavirus and 3,464 people died, the WHO said.

According to the latest situation report, the majority of the confirmed cases - more than 361,000 - are presently concentrated in Europe, with Italy leading the tally with over 92,000 cases, followed by Spain with over 72,000 cases, and Germany with over 52,000 cases.

Italy and Spain are also the countries that top the worldwide death toll from COVID-19, with 10,023 and 5,690 fatalities, respectively.

The second most affected region is currently the Americas with over 120,000 verified COVID-19 cases, of which the majority - over 103,000 - have been found in the United States. The US is also the country with the highest single tally of COVID-19 cases at the moment.
The WHO declared COVID-19 a pandemic on March 11.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.